Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing
Authors:
- Mini KambojMKMini Kamboj
- Jennifer BriteJBJennifer Brite
- Anoshe AslamAAAnoshe Aslam
- Jessica KenningtonJKJessica Kennington
- N. Esther BabadyNBN. Esther Babady
- David CalfeeDCDavid Calfee
- Yoko FuruyaYFYoko Furuya
- Donald ChenDCDonald Chen
- Michael AugenbraunMAMichael Augenbraun
- Belinda OstrowskyBOBelinda Ostrowsky
- Gopi PatelGPGopi Patel
- Monica MircescuMMMonica Mircescu
Open Access
- 1 March 2018
- journal article
- research article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 24 (3) , 584-587
Abstract
In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency.Keywords
This publication has 12 references indexed in Scilit:
- Toxin Immunoassays and Clostridium difficile Infection-Reply.JAMA Internal Medicine, 2016
- Burden ofClostridium difficileInfection in the United StatesNew England Journal of Medicine, 2015
- Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithmClinical Microbiology and Infection, 2014
- Early Clostridium difficile Infection during Allogeneic Hematopoietic Stem Cell TransplantationPLOS ONE, 2014
- Effect of Nucleic Acid Amplification Testing on Population-Based Incidence Rates of Clostridium difficile InfectionClinical Infectious Diseases, 2013
- Use of Multilocus Variable Number of Tandem Repeats Analysis Genotyping to Determine the Role of Asymptomatic Carriers in Clostridium difficile TransmissionClinical Infectious Diseases, 2013
- Impact of the Type of Diagnostic Assay on Clostridium difficile Infection and Complication Rates in a Mandatory Reporting ProgramClinical Infectious Diseases, 2012
- Host and Pathogen Factors forClostridium difficileInfection and ColonizationNew England Journal of Medicine, 2011
- Impact of PCR Testing for Clostridium difficile on Incident Rates and Potential on Public Reporting: Is the Playing Field Level?Infection Control & Hospital Epidemiology, 2011
- An Epidemic, Toxin Gene–Variant Strain ofClostridium difficileNew England Journal of Medicine, 2005